Shenzhen Liying Biotechnology

Shenzhen Liying Biotechnology

Specializes in protein design and modification for synthetic biology and biopharmaceutical applications.

HQ location
Shenzhen, China
Website
Launch date
Employees
Enterprise value
$55—83m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor

€0.0

round
investor

€0.0

round
*
N/A

CNY100m

Series A
Total Funding000k
Notes (0)
More about Shenzhen Liying Biotechnology
Made with AI
Edit

Lybio.com specializes in protein design and modification, offering high-quality and efficient research and development services for a wide range of protein applications. The company synthesizes protein materials and provides tailored solutions for various industries, including pharmaceuticals, biotechnology, and healthcare. The core technology founders and team members boast over a decade of experience from prestigious institutions such as the University of Oxford, the University of Cambridge, and the Francis Crick Institution. Lybio.com serves clients ranging from academic researchers to commercial enterprises, operating in the global biotechnology market. The business model revolves around providing contract research organization (CRO) and contract development and manufacturing organization (CDMO) services, generating revenue through project-based contracts and long-term partnerships.

Keywords: protein design, protein modification, R&D services, protein synthesis, biotechnology, pharmaceuticals, healthcare, CRO, CDMO, research expertise.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads